)
Beyond Air (XAIR) investor relations material
Beyond Air Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for the quarter ended December 31, 2025, increased 105% year-over-year to $2.2M, with over 45 hospitals adopting the LungFit PH system and international distribution agreements covering 40 countries.
Net loss attributable to common stockholders was $7.3M ($0.85/share) for the quarter, a significant improvement from $13M ($2.96/share) in the prior year.
Gross profit reached $0.3M, reversing a gross loss in the prior year, and customer retention exceeds 90% with more than half under multi-year agreements.
The company strengthened its balance sheet through a $4.5M equity financing, a $12M promissory note, and a binding agreement to sell 85% of NeuroNOS to XTL Biopharmaceuticals for equity, cash, and up to $32.5M in milestones.
Expanded global reach with CE mark approval in Europe, first sale to a VA Medical Center, and new distribution agreements in multiple countries.
Financial highlights
Revenue rose 105% year-over-year to $2.2M and 21% sequentially from the previous quarter, with nine-month revenue at $5.8M.
Gross profit for the quarter was $0.3M, with gross margin improving to 13.7% from negative in the prior year.
Operating expenses dropped 36% year-over-year to $6.9M, with SG&A down 42% and R&D down 19-20%.
Net loss narrowed to $7.3M ($0.85/share) from $13M ($2.96/share) year-over-year; net cash burn for the quarter was $4.3M.
Cash, cash equivalents, and marketable securities totaled $17.8M at quarter end, with a subsequent $4.5M equity financing and $18.8M equity line of credit available.
Outlook and guidance
Fiscal year 2026 revenue guidance remains at $8-10M, with cash runway expected into 2027 and potentially to profitability if targets are met.
Confident in FDA approval for the second-generation LungFit PH system by end of calendar 2026, pending contract manufacturer inspection.
Management expects continued net losses and cash outflows for at least the next twelve months and will require additional funding within one year.
Focus remains on expanding Gen 1 system utilization while preparing for Gen 2 launch and progressing international regulatory submissions.
Next Beyond Air earnings date
Next Beyond Air earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)